UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA

Gene therapy, 2019-09, Vol.26 (9), p.363-372

2019

Volltextzugriff (PDF)

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice

Nature communications, 2020-07, Vol.11 (1), p.3523-7, Article 3523

2020

Volltextzugriff (PDF)

RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?

Frontiers in immunology, 2020-12, Vol.11, p.608460-608460

2020

Volltextzugriff (PDF)

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice

Nature communications, 2021-05, Vol.12 (1), p.2893-2893, Article 2893

2021

Volltextzugriff (PDF)

Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines

Journal of controlled release, 2021-10, Vol.338, p.201-210

2021

Volltextzugriff (PDF)

Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice

PloS one, 2012-12, Vol.7 (12), p.e50529-e50529

2012

Volltextzugriff (PDF)

Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA

Molecular therapy, 2021-03, Vol.29 (3), p.1174-1185

2021

Volltextzugriff (PDF)

Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non-Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae

The Journal of immunology (1950), 2020-02, Vol.204 (4), p.903-913

2020

Volltextzugriff (PDF)

Selective transmission of R5 HIV-1 variants: where is the gatekeeper?

Journal of translational medicine, 2011-01, Vol.9 Suppl 1 (S1), p.S6-S6, Article S6

2011

Volltextzugriff (PDF)

Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice

Nature communications, 2024-02, Vol.15 (1), p.1665-1665, Article 1665

2024

Volltextzugriff (PDF)

Inhibiting sexual transmission of HIV-1 infection

Nature reviews. Microbiology, 2003-10, Vol.1 (1), p.25-34

2003

Volltextzugriff (PDF)

Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA

Journal of controlled release, 2019-06, Vol.304, p.65-74

2019

Volltextzugriff (PDF)

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

PLoS pathogens, 2015-08, Vol.11 (8), p.e1005042-e1005042

2015

Volltextzugriff (PDF)

An Overview of Rift Valley Fever Vaccine Development Strategies

Vaccines (Basel), 2022-10, Vol.10 (11), p.1794

2022

Volltextzugriff (PDF)

Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines

PLoS pathogens, 2022-10, Vol.18 (10), p.e1010885-e1010885

2022

Volltextzugriff (PDF)

Turning the Tide Against HIV

Science (American Association for the Advancement of Science), 2011-07, Vol.333 (6038), p.42-43

2011

Volltextzugriff (PDF)

Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection

PloS one, 2016-01, Vol.11 (1), p.e0143109-e0143109

2016

Volltextzugriff (PDF)

Innate activation of human primary epithelial cells broadens the host response to Mycobacterium tuberculosis in the airways

PLoS pathogens, 2017-09, Vol.13 (9), p.e1006577-e1006577

2017

Volltextzugriff (PDF)

Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component

Proceedings of the National Academy of Sciences - PNAS, 2009-04, Vol.106 (15), p.6099-6104

2009

Volltextzugriff (PDF)

Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers

Cell reports (Cambridge), 2018-09, Vol.24 (12), p.3324-3338.e5

2018

Volltextzugriff (PDF)

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140

PloS one, 2012-07, Vol.7 (7), p.e41144-e41144

2012

Volltextzugriff (PDF)

TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes

PloS one, 2016-02, Vol.11 (2), p.e0148984-e0148984

2016

Volltextzugriff (PDF)

Increasing human monoclonal antibody cloning efficiency with a whole-cell modified immunoglobulin-capture assay (mICA)

Frontiers in immunology, 2023-06, Vol.14, p.1184510-1184510

2023

Volltextzugriff (PDF)

Reverse Transcriptase Inhibitors as Potential Colorectal Microbicides

Antimicrobial Agents and Chemotherapy, 2009-05, Vol.53 (5), p.1797-1807

2009

Volltextzugriff (PDF)

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial

PloS one, 2015-06, Vol.10 (6), p.e0131748-e0131748

2015

Volltextzugriff (PDF)

1 – 25 von 281

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(252)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(215)
Life Sciences & Biomedicine
(178)
Humans
(146)
Immunology
(94)
Female
(88)
Animals
(81)
Human Immunodeficiency Virus
(75)
Virology
(72)
Hiv
(67)
Human Immunodeficiency Virus 1
(61)
Vaccines
(61)
Infectious Diseases
(54)
Biological And Medical Sciences
(49)
Hiv Infections - Prevention & Control
(47)
Microbiology
(43)
Hiv-1
(39)
Infections
(39)
Male
(37)
Hiv Infections - Immunology
(36)
Medicine, Research & Experimental
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(25)
Journal Of Virology
(16)
Aids
(14)
Frontiers In Immunology
(13)
Aids Research And Human Retroviruses
(11)
Vaccine
(11)
Journal Of Controlled Release
(10)
The Journal Of Immunology
(8)
Antimicrobial Agents And Chemotherapy
(7)
Retrovirology
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice

RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice

Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines

Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice

Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA

Chemokine-Adjuvanted Plasmid DNA Induces Homing of Antigen-Specific and Non-Antigen-Specific B and T Cells to the Intestinal and Genital Mucosae

Selective transmission of R5 HIV-1 variants: where is the gatekeeper?

Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice

Inhibiting sexual transmission of HIV-1 infection

Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

An Overview of Rift Valley Fever Vaccine Development Strategies

Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines

Turning the Tide Against HIV

Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection

Innate activation of human primary epithelial cells broadens the host response to Mycobacterium tuberculosis in the airways

Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component

Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers

Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140

TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes

Increasing human monoclonal antibody cloning efficiency with a whole-cell modified immunoglobulin-capture assay (mICA)

Reverse Transcriptase Inhibitors as Potential Colorectal Microbicides

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial

Suchergebnisse filtern